(Q38017727)

27 August 2017

title

Targeting the liver kinase B1/AMP-activated protein kinase pathway as a therapeutic strategy for hematological malignancies (English)

1 reference

27 August 2017

Francesca Chiarini

2

0 references

Camilla Evangelisti

object named as

Camilla Evangelisti

3

0 references

James A. McCubrey

object named as

James A McCubrey

9

0 references

author name string

Alberto M Martelli

1

1 reference

27 August 2017

Andrea Ognibene

4

1 reference

27 August 2017

Daniela Bressanin

5

1 reference

27 August 2017

Anna Maria Billi

6

1 reference

27 August 2017

Lucia Manzoli

7

1 reference

27 August 2017

Alessandra Cappellini

8

1 reference

27 August 2017

language of work or name

English

0 references

publication date

12 June 2012

1 reference

Expert Opinion on Therapeutic Targets

27 August 2017

published in

1 reference

27 August 2017

volume

16

1 reference

27 August 2017

issue

7

1 reference

27 August 2017

page(s)

729-742

1 reference

AMP-activated protein kinase: an energy sensor that regulates all aspects of cell function

27 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2012.694869

LKB1 is the upstream kinase in the AMP-activated protein kinase cascade

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2012.694869

A serine/threonine kinase gene defective in Peutz-Jeghers syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2012.694869

The long and winding road to rational treatment of cancer associated with LKB1/AMPK/TSC/mTORC1 signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2012.694869

Somatic LKB1 mutations promote cervical cancer progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2012.694869

Complexes between the LKB1 tumor suppressor, STRAD alpha/beta and MO25 alpha/beta are upstream kinases in the AMP-activated protein kinase cascade

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2012.694869

Activation of the tumour suppressor kinase LKB1 by the STE20-like pseudokinase STRAD

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2012.694869

MO25alpha/beta interact with STRADalpha/beta enhancing their ability to bind, activate and localize LKB1 in the cytoplasm

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2012.694869

Acadesine activates AMPK and induces apoptosis in B-cell chronic lymphocytic leukemia cells but not in T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2012.694869

Activation of adenosine monophosphate activated protein kinase inhibits growth of multiple myeloma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2012.694869

Stabilization and activation of p53 downregulates mTOR signaling through AMPK in mantle cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2012.694869

Resveratrol promotes autophagic cell death in chronic myelogenous leukemia cells via JNK-mediated p62/SQSTM1 expression and AMPK activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2012.694869

The LKB1/AMPK signaling pathway has tumor suppressor activity in acute myeloid leukemia through the repression of mTOR-dependent oncogenic mRNA translation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2012.694869

AMP-dependent kinase/mammalian target of rapamycin complex 1 signaling in T-cell acute lymphoblastic leukemia: therapeutic implications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2012.694869

AMPK and mTOR in cellular energy homeostasis and drug targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2012.694869

AMP-activated/SNF1 protein kinases: conserved guardians of cellular energy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2012.694869

Structure of mammalian AMPK and its regulation by ADP

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2012.694869

Calmodulin-dependent protein kinase kinase-beta is an alternative upstream kinase for AMP-activated protein kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2012.694869

Activation of yeast Snf1 and mammalian AMP-activated protein kinase by upstream kinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2012.694869

Mammalian TAK1 activates Snf1 protein kinase in yeast and phosphorylates AMP-activated protein kinase in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2012.694869

Regulation of the energy sensor AMP-activated protein kinase by antigen receptor and Ca2+ in T lymphocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2012.694869

Phosphorylation and activation of heart PFK-2 by AMPK has a role in the stimulation of glycolysis during ischaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2012.694869

Malonyl-CoA, a key signaling molecule in mammalian cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2012.694869

The CREB coactivator TORC2 is a key regulator of fasting glucose metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2012.694869

AMP-activated protein kinase (AMPK) action in skeletal muscle via direct phosphorylation of PGC-1alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2012.694869

Complementary regulation of TBC1D1 and AS160 by growth factors, insulin and AMPK activators

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2012.694869

Regulation of multisite phosphorylation and 14-3-3 binding of AS160 in response to IGF-1, EGF, PMA and AICAR.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2012.694869

Class IIa histone deacetylases are hormone-activated regulators of FOXO and mammalian glucose homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2012.694869

AMP-activated protein kinase regulates GLUT4 transcription by phosphorylating histone deacetylase 5

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2012.694869

Inhibition of contraction-stimulated AMP-activated protein kinase inhibits contraction-stimulated increases in PAS-TBC1D1 and glucose transport without altering PAS-AS160 in rat skeletal muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2012.694869

Metformin induces Rab4 through AMPK and modulates GLUT4 translocation in skeletal muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2012.694869

Transcriptional control of mitochondrial biogenesis: the central role of PGC-1alpha.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2012.694869

Interdependence of AMPK and SIRT1 for metabolic adaptation to fasting and exercise in skeletal muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2012.694869

Activation of AMP-activated protein kinase leads to the phosphorylation of elongation factor 2 and an inhibition of protein synthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2012.694869

AMPK and mTOR regulate autophagy through direct phosphorylation of Ulk1

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2012.694869

The role of the Atg1/ULK1 complex in autophagy regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2012.694869

mTOR: from growth signal integration to cancer, diabetes and ageing

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2012.694869

Dissecting the role of mTOR: lessons from mTOR inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2012.694869

mTOR is the rapamycin-sensitive kinase that confers mechanically-induced phosphorylation of the hydrophobic motif site Thr(389) in p70(S6k)

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2012.694869

Mechanism of PDK1-catalyzed Thr-229 phosphorylation of the S6K1 protein kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2012.694869

Regulation of ribosomal protein S6 phosphorylation by casein kinase 1 and protein phosphatase 1

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2012.694869

Interferon-dependent engagement of eukaryotic initiation factor 4B via S6 kinase (S6K)- and ribosomal protein S6K-mediated signals

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2012.694869

Translation inhibitor Pdcd4 is targeted for degradation during tumor promotion

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2012.694869

TDP-43 regulates global translational yield by splicing of exon junction complex component SKAR.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2012.694869

Regulation of elongation factor 2 kinase by p90(RSK1) and p70 S6 kinase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2012.694869

The biological and therapeutic relevance of mRNA translation in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2012.694869

Eukaryotic initiation factor 4F: a vulnerability of tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2012.694869

Targeting the translational apparatus to improve leukemia therapy: roles of the PI3K/PTEN/Akt/mTOR pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2012.694869

Targeting translation in acute myeloid leukemia: a new paradigm for therapy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2012.694869

The role of TOR in autophagy regulation from yeast to plants and mammals

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2012.694869

Role of AMPK-mTOR-Ulk1/2 in the regulation of autophagy: cross talk, shortcuts, and feedbacks

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2012.694869

Identification of the tuberous sclerosis complex-2 tumor suppressor gene product tuberin as a target of the phosphoinositide 3-kinase/akt pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2012.694869

21 January 2018

The two TORCs and Akt.

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2012.694869

TSC2 mediates cellular energy response to control cell growth and survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2012.694869

Inactivation of Rheb by PRAK-mediated phosphorylation is essential for energy-depletion-induced suppression of mTORC1

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2012.694869

Cell-type-dependent regulation of mTORC1 by REDD1 and the tumor suppressors TSC1/TSC2 and LKB1 in response to hypoxia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2012.694869

Metformin, independent of AMPK, inhibits mTORC1 in a rag GTPase-dependent manner

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2012.694869

AMPK phosphorylation of raptor mediates a metabolic checkpoint

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2012.694869

Regulation of the TSC pathway by LKB1: evidence of a molecular link between tuberous sclerosis complex and Peutz-Jeghers syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2012.694869

The LKB1 tumor suppressor negatively regulates mTOR signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2012.694869

Dysfunctional AMPK activity, signalling through mTOR and survival in response to energetic stress in LKB1-deficient lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2012.694869

Cardiac-specific deletion of LKB1 leads to hypertrophy and dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2012.694869

The LKB1-AMPK pathway: metabolism and growth control in tumour suppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2012.694869

Pharmacological management of type 2 diabetes mellitus: an update

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2012.694869

LKB1 and mammalian target of rapamycin as predictive factors for the anticancer efficacy of metformin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2012.694869

Metformin inhibits mammalian target of rapamycin-dependent translation initiation in breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2012.694869

Use of cells expressing gamma subunit variants to identify diverse mechanisms of AMPK activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2012.694869

Regulation of TORC1 by Rag GTPases in nutrient response

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2012.694869

The Rag GTPases bind raptor and mediate amino acid signaling to mTORC1

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2012.694869

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2012.694869

New oral therapies for type 2 diabetes mellitus: The glitazones or insulin sensitizers

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2012.694869

The Anti-diabetic drugs rosiglitazone and metformin stimulate AMP-activated protein kinase through distinct signaling pathways.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2012.694869

Rosiglitazone suppresses human lung carcinoma cell growth through PPARgamma-dependent and PPARgamma-independent signal pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2012.694869

Different effects of thiazolidinediones on cardiovascular risk in patients with type 2 diabetes mellitus: pioglitazone versus rosiglitazone

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2012.694869

Inhibition of lipolysis and lipogenesis in isolated rat adipocytes with AICAR, a cell-permeable activator of AMP-activated protein kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2012.694869

5-aminoimidazole-4-carboxamide ribonucleoside. A specific method for activating AMP-activated protein kinase in intact cells?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2012.694869

Structure of a CBS-domain pair from the regulatory gamma1 subunit of human AMPK in complex with AMP and ZMP

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2012.694869

Identification and characterization of a small molecule AMPK activator that treats key components of type 2 diabetes and the metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2012.694869

Berberine and its more biologically available derivative, dihydroberberine, inhibit mitochondrial respiratory complex I: a mechanism for the action of berberine to activate AMP-activated protein kinase and improve insulin action

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2012.694869

Mechanism of inhibition of bovine F1-ATPase by resveratrol and related polyphenols

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2012.694869

Metformin and reduced risk of cancer in diabetic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2012.694869

New users of metformin are at low risk of incident cancer: a cohort study among people with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2012.694869

Minireview: IGF, Insulin, and Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2012.694869

Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2012.694869

Diabetes mellitus and breast cancer: a retrospective population-based cohort study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2012.694869

Important role of the LKB1-AMPK pathway in suppressing tumorigenesis in PTEN-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2012.694869

Histological evaluation of AMPK signalling in primary breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2012.694869

Insulin antagonizes ischemia-induced Thr172 phosphorylation of AMP-activated protein kinase alpha-subunits in heart via hierarchical phosphorylation of Ser485/491.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2012.694869

Drugging the PI3 kinome: from chemical tools to drugs in the clinic.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2012.694869

Metformin in Cancer Therapy: A New Perspective for an Old Antidiabetic Drug?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2012.694869

Metformin and cancer therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2012.694869

Metformin: multi-faceted protection against cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2012.694869

Metformin and neoplasia: implications and indications

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2012.694869

Signal transduction inhibitors in chronic lymphocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2012.694869

AICAR induces apoptosis independently of AMPK and p53 through up-regulation of the BH3-only proteins BIM and NOXA in chronic lymphocytic leukemia cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2012.694869

The Bcl-2 apoptotic switch in cancer development and therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2012.694869

Acadesine kills chronic myelogenous leukemia (CML) cells through PKC-dependent induction of autophagic cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2012.694869

Optimizing the selection of kinase inhibitors for chronic myeloid leukemia patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2012.694869

Antileukemic effects of AMPK activators on BCR-ABL-expressing cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2012.694869

AMPK- and p62/SQSTM1-dependent autophagy mediate resveratrol-induced cell death in chronic myelogenous leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2012.694869

Biology, risk stratification, and therapy of pediatric acute leukemias: an update

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2012.694869

Cytotoxic effect of 5-aminoimidazole-4-carboxamide-1-beta-4-ribofuranoside (AICAR) on childhood acute lymphoblastic leukemia (ALL) cells: implication for targeted therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2012.694869

Regulation of the mTOR complex 1 pathway by nutrients, growth factors, and stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2012.694869

Mammalian target of rapamycin (mTOR) inhibition activates phosphatidylinositol 3-kinase/Akt by up-regulating insulin-like growth factor-1 receptor signaling in acute myeloid leukemia: rationale for therapeutic inhibition of both pathways.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2012.694869

AMPK-induced activation of Akt by AICAR is mediated by IGF-1R dependent and independent mechanisms in acute lymphoblastic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2012.694869

ETV6-RUNX1-positive childhood acute lymphoblastic leukemia: improved outcome with contemporary therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2012.694869

AMPK and Akt determine apoptotic cell death following perturbations of one-carbon metabolism by regulating ER stress in acute lymphoblastic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2012.694869

AMP-activated protein kinase promotes human prostate cancer cell growth and survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2012.694869

Methotrexate enhances the antianabolic and antiproliferative effects of 5-aminoimidazole-4-carboxamide riboside.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2012.694869

PTEN posttranslational inactivation and hyperactivation of the PI3K/Akt pathway sustain primary T cell leukemia viability

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2012.694869

Genome-wide RNA-mediated interference screen identifies miR-19 targets in Notch-induced T-cell acute lymphoblastic leukaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2012.694869

Acadesine induces apoptosis in B cells from mantle cell lymphoma and splenic marginal zone lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2012.694869

p53 target genes sestrin1 and sestrin2 connect genotoxic stress and mTOR signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2012.694869

Functional interleukin-7 receptors (IL-7Rs) are expressed by marrow stromal cells: binding of IL-7 increases levels of IL-6 mRNA and secreted protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2012.694869

Autophagy augmented by troglitazone is independent of EGFR transactivation and correlated with AMP-activated protein kinase signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2012.694869

Evidence for biological effects of metformin in operable breast cancer: a pre-operative, window-of-opportunity, randomized trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2012.694869

The antidiabetic drug metformin exerts an antitumoral effect in vitro and in vivo through a decrease of cyclin D1 level.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2012.694869

Dual inhibition of PI3K and mTORC1/2 signaling by NVP-BEZ235 as a new therapeutic strategy for acute myeloid leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2012.694869

Targeted inhibition of mTORC1 and mTORC2 by active-site mTOR inhibitors has cytotoxic effects in T-cell acute lymphoblastic leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2012.694869

RNA interference-mediated silencing of the acetyl-CoA-carboxylase-alpha gene induces growth inhibition and apoptosis of prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2012.694869

Acetyl-CoA carboxylase alpha is essential to breast cancer cell survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2012.694869

Cell cycle regulation in hematopoietic stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2012.694869

Lkb1 regulates cell cycle and energy metabolism in haematopoietic stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2012.694869

The Lkb1 metabolic sensor maintains haematopoietic stem cell survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2012.694869

Lkb1 regulates quiescence and metabolic homeostasis of haematopoietic stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2012.694869

The emerging role of the phosphatidylinositol 3-kinase/Akt/mammalian target of rapamycin signaling network in normal myelopoiesis and leukemogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2012.694869

Targeting the leukemic stem cell: the Holy Grail of leukemia therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2012.694869

Targeted elimination of leukemia stem cells; a new therapeutic approach in hemato-oncology

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2012.694869

The 5' adenosine monophosphate-activated protein kinase: regulating the ebb and flow of cellular energetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2012.694869

10.1517/14728222.2012.694869

21 January 2018

Identifiers

DOI

1 reference

27 August 2017

1 reference